QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$38.91 USD
+0.67 (1.75%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $38.88 -0.03 (-0.08%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
QDEL 38.91 +0.67(1.75%)
Will QDEL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for QDEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QDEL
Here's Why You Should Retain QuidelOrtho (QDEL) Stock for Now
Strength Seen in National Vision (EYE): Can Its 7.2% Jump Turn into More Strength?
QDEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is QuidelOrtho (QDEL) Down 2.4% Since Last Earnings Report?
QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall
Here's What Key Metrics Tell Us About QuidelOrtho (QDEL) Q1 Earnings
Other News for QDEL
Avantor to replace QuidelOrtho in S&P 400 at open 7/26
QuidelOrtho to replace Hibbett in S&P 600 at open on 7/26
Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600
Avantor to replace QuidelOrtho in S&P 400 at open 7/26
QuidelOrtho to replace Hibbett in S&P 600 at open on 7/26